Marshall Wace North America’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-180,957
Closed -$7.52M 1589
2020
Q4
$7.52M Buy
180,957
+74,526
+70% +$3.11M 0.03% 443
2020
Q3
$4.52M Buy
+106,431
New +$4.59M 0.03% 417
2020
Q2
Sell
-82,158
Closed -$2.69M 1255
2020
Q1
$2.69M Sell
82,158
-50,868
-38% -$1.89M 0.02% 431
2019
Q4
$4.9M Buy
133,026
+27,908
+27% +$990K 0.02% 393
2019
Q3
$3.53M Sell
105,118
-54,534
-34% -$1.93M 0.02% 431
2019
Q2
$6.27M Buy
159,652
+32,016
+25% +$1.27M 0.04% 314
2019
Q1
$5.17M Buy
127,636
+105,765
+484% +$3.94M 0.04% 321
2018
Q4
$708K Buy
+21,871
New +$883K 0.01% 693
2018
Q2
Sell
-44,617
Closed -$2.28M 1484
2018
Q1
$2.28M Sell
44,617
-47,623
-52% -$2.54M 0.01% 780
2017
Q4
$4.85M Buy
92,240
+76,318
+479% +$3.79M 0.03% 589
2017
Q3
$780K Buy
+15,922
New +$757K ﹤0.01% 996

Other funds holding FMS

Marshall Wace North America's FMS Position: Q1 2021 in Review

Marshall Wace North America sold out of Fresenius Medical Care (FMS) in Q1 2021, closing a stake of 180,957 shares — an estimated $7.52M sold.

Marshall Wace North America first reported a position in FMS in Q3 2017 and held it in 11 quarters. The position peaked at $7.52M in Q4 2020. 167 funds tracked by Wall St. Rank hold FMS as of Q1 2021.

  • Marshall Wace North America reported no remaining Fresenius Medical Care position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 180,957 Fresenius Medical Care shares in Q1 2021, an estimated $7.52M.
  • Marshall Wace North America first reported a position in Fresenius Medical Care in Q3 2017 and held it in 11 quarters.
  • Marshall Wace North America's Fresenius Medical Care position peaked at $7.52M in Q4 2020.
  • 167 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.